"QPS Miami Research is a leading global research organization specializing in clinical development services to the pharmaceutical and biotechnological industry since 1996. Our regional laboratories and testing facilities are located at: Florida, Delaware, Missouri, North Carolina, The Netherlands, Austria, India, Taiwan and Taipei."

During the past decade, Miami Research Associates conducted 126 clinical trials. In the 10-year time frame, 126 clinical trials started and 115 clinical trials were completed, i.e. on average, 91.3% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 56 clinical trials were completed. i.e. 160% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Miami Research Associates" #1 sponsor was "Pfizer" with 59 trials, followed by "Bristol-Myers Squibb" with 15 trials sponsored, "Eli Lilly and Company" with 15 trials sponsored, "Shire" with 15 trials sponsored and "Sunovion" with 15 trials sponsored. Other sponsors include 178 different institutions and companies that sponsored additional 108 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Miami Research Associates" #1 collaborator was "Department of Health and Human Services" with 9 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials as a collaborator, "Pfizer" with 4 trials as a collaborator, "Elan Pharmaceuticals" with 2 trials as a collaborator and "KGK Science Inc." with 2 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Miami Research Associates" are "Healthy" (19 trials), "Influenza" (13 trials), "ADHD" (10 trials), "Diabetes Mellitus, Type 2" (10 trials) and "Attention Deficit Hyperactivity Disorder (ADHD)" (8 trials). Many other conditions were trialed in "Miami Research Associates" in a lesser frequency.

Most popular intervention types in "Miami Research Associates" are "Drug" (217 trials), "Biological" (75 trials), "Other" (22 trials), "Device" (5 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (120 trials), "Dasotraline" (4 trials), "Dulaglutide" (4 trials), "Rimegepant" (4 trials) and "BioThrax" (3 trials). Other intervention names were less common.

The vast majority of trials in "Miami Research Associates" are 270 trials for "All" genders, 22 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Miami Research Associates". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 261 completed trials in Miami Research Associates, undefined suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Miami Research Associates, 93 "Phase 1" clinical trials were conducted, 90 "Phase 2" clinical trials and 105 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 6 trials that are defined as “Not Applicable".